Attention, focus, and impulse control are governed by specific, measurable brain networks. MeRT® maps those networks with a qEEG, then builds a personalized, non-invasive protocol around what it finds.
Many people with ADHD manage well with medication, therapy, or both — but some find stimulant medications come with side effects they'd rather avoid, or that symptoms persist despite treatment. MeRT offers a different starting point: a map of your brain's own attention-related activity.
If medication side effects limit your quality of life, MeRT works through a different, non-pharmaceutical mechanism.
Whether focus, hyperactivity, or both are the primary challenge, your protocol is built around your own qEEG findings.
Our functional medicine evaluation considers what else may be affecting focus and regulation, alongside your MeRT protocol.
A qEEG brain map identifies the specific patterns associated with your attention and regulation difficulties. Dr. Wallace reviews that data and builds your protocol around it, and the EEG is repeated during treatment so the protocol can adjust as you respond.
The rTMS equipment used in MeRT is FDA-cleared for depression and OCD. Use for ADHD is considered off-label, and insurance coverage for ADHD specifically is unlikely — our team can review your options during a benefits check.

Oversees all clinical protocols. Reviews every EEG, approves every treatment protocol, and conducts results appointments. Dr. Wallace evaluates relevant root-cause factors as part of your MeRT intake — the scope of functional medicine evaluation is determined on a per-patient basis.
View full profile →Conducts intake evaluations, documents prior treatment history, manages medication questions, and generates insurance authorization documentation where applicable.
View full profile →Is this instead of medication, or alongside it?
Either can work, depending on your situation. Many patients continue their current medication while going through MeRT; your physician team will discuss what makes sense for you.
Is MeRT for ADHD FDA-cleared?
The rTMS equipment used in MeRT is FDA-cleared for depression and OCD. Use for ADHD is considered off-label, following a full evaluation.
Does insurance cover this?
Coverage for ADHD specifically is unlikely, since it's an off-label use. Our team can verify your specific benefits before you commit to anything.
Want to talk through your specific situation? care team can answer your questions with no obligation.
Ready to try a different approach to ADHD?
Request Consultation